The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs
Open accessAbstract
ABSTRACT Fused deposition modelling (FDM) is the most commonly investigated 3D printing technology for the manufacture of personalized medicines, however, the high temperatures used in the process limit its wider application. The objective of this study was to print low‐melting and thermolabile drugs by reducing the FDM printing temperature. Two immediate release polymers, Kollidon VA64 and Kollidon 12PF were investigated as potential candidates for low‐temperature FDM printing. Ramipril was used as the model low melting temperature drug (109°C); to the authors’ knowledge this is the lowest melting point drug investigated to date by FDM printing. Filaments loaded with 3% drug were obtained by hot melt extrusion at 70°C and ramipril printlets with a dose equivalent of 8.8mg were printed at 90°C. HPLC analysis confirmed that the drug was stable with no signs of degradation and dissolution studies revealed that drug release from the printlets reached 100% within 20–30min. Variable temperature Raman and solid state nuclear magnetic resonance (SSNMR) spectroscopy techniques were used to evaluate drug stability over the processing temperature range. These data indicated that ramipril did not undergo degradation below its melting point (which is above the processing temperature range: 70–90°C) but it was transformed into the impurity diketopiperazine upon exposure to temperatures higher than its melting point. The use of the excipients Kollidon VA64 and Kollidon 12PF in FDM was further validated by printing with the drug 4‐aminosalicylic acid (4‐ASA), which in previous work was reported to undergo degradation in FDM printing, but here it was found to be stable. This work demonstrates that the selection and use of new excipients can overcome one of the major disadvantages in FDM printing, drug degradation due to thermal heating, making this technology suitable for drugs with lower melting temperatures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Modelling one‐ and two‐dimensional solid‐state NMR spectra
Massiot, D., Fayon, F., Capron, M., King, I., Le Calvé, S., Alonso, B., Durand, J., Bujoli, B., Gan, Z., & Hoatson, G. (2002) · Magnetic Resonance in Chemistry · doi:10.1002/mrc.984 · Cited by 4,279
An Improved Broadband Decoupling Sequence for Liquid Crystals and Solids
Fung, B. M., Khitrin, A. K., & Ermolaev, K. (2000) · Journal of Magnetic Resonance · doi:10.1006/jmre.1999.1896 · Cited by 1,987
Recent advances in 3D printing of biomaterials
Chia, H. N., & Wu, B. M. (2015) · Journal of Biological Engineering · doi:10.1186/s13036-015-0001-4 · Cited by 1,734
Chemical shift referencing in MAS solid state NMR
Morcombe, C. R., & Zilm, K. W. (2003) · Journal of Magnetic Resonance · doi:10.1016/s1090-7807(03)00082-x · Cited by 862
Effect of geometry on drug release from 3D printed tablets
Goyanes, A., Robles Martinez, P., Buanz, A., Basit, A. W., & Gaisford, S. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.04.069 · Cited by 667
Self-citation3D printing in pharmaceutics: A new tool for designing customized drug delivery systems
Goole, J., & Amighi, K. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.12.071 · Cited by 660
Stereolithographic (SLA) 3D printing of oral modified-release dosage forms
Wang, J., Goyanes, A., Gaisford, S., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.03.016 · Cited by 612
Self-citationKhaled, S. A., Burley, J. C., Alexander, M. R., Yang, J., & Roberts, C. J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.028 · Cited by 606
Fused-filament 3D printing (3DP) for fabrication of tablets
Goyanes, A., Buanz, A. B. M., Basit, A. W., & Gaisford, S. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.044 · Cited by 587
Self-citationSelective laser sintering (SLS) 3D printing of medicines
Fina, F., Goyanes, A., Gaisford, S., & Basit, A. W. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.082 · Cited by 577
Self-citation
Cited by
Recent Developments in Fused Deposition Modeling-Based 3D Printing of Polymers and Their Composites
Rahim, T. N. A. T., Abdullah, A. M., & Md Akil, H. (2019) · Polymer Reviews · doi:10.1080/15583724.2019.1597883 · Cited by 452
Current status and future directions of fused filament fabrication
Singh, S., Singh, G., Prakash, C., & Ramakrishna, S. (2020) · Journal of Manufacturing Processes · doi:10.1016/j.jmapro.2020.04.049 · Cited by 385
Azad, M. A., Olawuni, D., Kimbell, G., Badruddoza, A. Z. M., Hossain, M. S., & Sultana, T. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020124 · Cited by 356
3D Printing of a Multi-Layered Polypill Containing Six Drugs Using a Novel Stereolithographic Method
Robles-Martinez, P., Xu, X., Trenfield, S. J., Awad, A., Goyanes, A., Telford, R., Basit, A. W., & Gaisford, S. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11060274 · Cited by 358
Self-citationTan, D. K., Maniruzzaman, M., & Nokhodchi, A. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10040203 · Cited by 329
Metadata
- Authors
- Kollamaram, G., Croker, D. M., Walker, G. M., Goyanes, A., Basit, A. W., & Gaisford, S.
- Venue
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 545
- Issue
- 1-2
- Pages
- 144-152
- ISSN
- 0378-5173 (ISSN-L)
- OpenAlex
- W2800695185
- Cited by
- 318
- References
- 45
- FWCI
- 21.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. https://app.cochat.ai/papers/10.1016/j.ijpharm.2018.04.055
- The paper
- Kollamaram, G., Croker, D. M., Walker, G. M., Goyanes, A., Basit, A. W., & Gaisford, S. (2018). Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs. International Journal of Pharmaceutics. https://doi.org/10.1016/j.ijpharm.2018.04.055
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.